An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Seres Therapeutics to Participate in Upcoming Virtual Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Seres Therapeutics, Inc. (Nasdaq: MCRB) announced participation in three investor conferences. Management will engage in a pre-recorded fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021. Additionally, a fireside chat is scheduled for September 15, 2021, at the Morgan Stanley 19th Annual Global Healthcare Conference. Lastly, Seres will hold investor meetings during the Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit on September 22, 2021. Webcast replays will be available on their website post-event.
Positive
None.
Negative
None.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that management will participate in three upcoming investor conferences:
H.C. Wainwright 23rd Annual Global Investment Conference: Seres will participate in a pre-recorded fireside chat that will be made available on Monday, September 13, 2021 at 7:00 a.m. ET.
Morgan Stanley 19th Annual Global Healthcare Conference: Seres will participate in a fireside chat on Wednesday, September 15, 2021 at 11:00 a.m. ET.
Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit: Seres will host meetings with investors on Wednesday, September 22, 2021.
A webcast replay will be available on the Seres website beginning approximately two hours after each webcast event and will be archived for approximately 21 days.
About Seres Therapeutics
Seres Therapeutics, Inc. (Nasdaq: MCRB) is a leading microbiome therapeutics company developing a novel class of multifunctional bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. Seres’ SER-109 program achieved the first-ever positive pivotal clinical results for a targeted microbiome drug candidate and has obtained Breakthrough Therapy and Orphan Drug designations from the FDA. The SER-109 program is being advanced for the treatment of recurrent C. difficile infection and has potential to become a first-in-class FDA-approved microbiome therapeutic. Seres is evaluating SER-301 in a Phase 1b study in patients with ulcerative colitis and SER-155 in a Phase 1b study to address gastrointestinal infections, bacteremia and graft-versus-host disease. For more information, please visit www.serestherapeutics.com.
What conferences is Seres Therapeutics participating in September 2021?
Seres Therapeutics is participating in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, the Morgan Stanley 19th Annual Global Healthcare Conference on September 15, and the Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit on September 22.
When will the fireside chat at the H.C. Wainwright Conference be available?
The fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference will be available on September 13, 2021, at 7:00 a.m. ET.
What is the significance of the SER-109 program by Seres Therapeutics?
The SER-109 program is notable for achieving positive pivotal clinical results and has received Breakthrough Therapy and Orphan Drug designations from the FDA for treating recurrent C. difficile infection.
Where can I find the webcast replays of Seres Therapeutics' events?
Webcast replays of Seres Therapeutics' events will be available on their website approximately two hours after each event, archived for about 21 days.
What is the stock symbol for Seres Therapeutics?
The stock symbol for Seres Therapeutics is MCRB, and it is listed on Nasdaq.
